{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    10,
    11,
    12,
    26,
    28,
    29,
    33,
    34,
    35,
    36,
    37,
    41,
    42,
    43,
    50
  ],
  "modelUsed": "gemini-3-flash-preview",
  "confidence": 1.0,
  "documentStructure": {
    "documentContentReferences": [
      {
        "id": "ref_1",
        "name": "Exploratory Substudy Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "2.6",
        "sectionTitle": "Exploratory Substudy",
        "description": "Reference to language allowing the Sponsor to propose exploratory substudies."
      },
      {
        "id": "ref_2",
        "name": "Sample Size Rationale Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "3.1.1, 3.1.1.1, 4.1, 6, 6.1, 9.5",
        "sectionTitle": "Multiple Sections",
        "description": "References regarding sample size increase to mitigate loss of data and protocol deviations."
      },
      {
        "id": "ref_3",
        "name": "Missed Samples Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "3.1.2",
        "sectionTitle": "Compliance with Study Visits",
        "description": "Reference to handling missed PK, PD, or ADA samples."
      },
      {
        "id": "ref_4",
        "name": "Appendix 1 Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "Appendix 1",
        "sectionTitle": "Schedule of Activities",
        "description": "Reference for obtaining missed samples at the next scheduled visit."
      },
      {
        "id": "ref_5",
        "name": "IMP Transit Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "4.3.3",
        "sectionTitle": "Investigational Medicinal Product Transit",
        "description": "Reference to temperature and time monitoring during transit."
      },
      {
        "id": "ref_6",
        "name": "Visual Functioning Questionnaire Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "4.5.8.1",
        "sectionTitle": "NEI VFQ-25 Administration",
        "description": "Clarification on the administration of the NEI VFQ-25."
      },
      {
        "id": "ref_7",
        "name": "Medical Monitor Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "5.4.1",
        "sectionTitle": "Medical Monitors and Emergency Medical Contacts",
        "description": "Update to Medical Monitors and Emergency Medical Contacts."
      },
      {
        "id": "ref_8",
        "name": "Pregnancy Notification Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "5.4.3.1",
        "sectionTitle": "Pregnancy Notification",
        "description": "Reference to Informed Consent Form instructions for female patients."
      },
      {
        "id": "ref_9",
        "name": "Safety Population Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "6.2.5",
        "sectionTitle": "Safety Population",
        "description": "Clarification of the faricimab-pooled safety population."
      },
      {
        "id": "ref_10",
        "name": "Immunogenicity Population Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "6.2.7",
        "sectionTitle": "Immunogenicity Analysis Population",
        "description": "Clarification of the immunogenicity analysis population."
      },
      {
        "id": "ref_11",
        "name": "Data Sharing Policy Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "9.6",
        "sectionTitle": "Dissemination of Data and Protection of Trade Secrets",
        "description": "Correction of the name of a Roche policy on data sharing."
      },
      {
        "id": "ref_12",
        "name": "Appendix 10 Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "Appendix 10",
        "sectionTitle": "National Eye Institute 25-Item Visual Functioning Questionnaire",
        "description": "Reference to updated and added pages to the NEI VFQ-25."
      },
      {
        "id": "ref_13",
        "name": "Study Treatment Details Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "4.3.1",
        "sectionTitle": "Study Treatment",
        "description": "Reference for further details on study drug and sham procedure."
      },
      {
        "id": "ref_14",
        "name": "Visual Acuity Assessment Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "4.5.5",
        "sectionTitle": "Visual Acuity",
        "description": "Reference for BCVA assessment on the ETDRS chart."
      },
      {
        "id": "ref_15",
        "name": "PTI Dosing Criteria Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "3.1.4.1",
        "sectionTitle": "PTI Dosing Criteria",
        "description": "Reference for PTI dosing criteria in Part 2 of the study."
      },
      {
        "id": "ref_16",
        "name": "Masking Details Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "4.2.2",
        "sectionTitle": "Masking",
        "description": "Reference for additional details on masking requirements."
      },
      {
        "id": "ref_17",
        "name": "Eligibility Criteria Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "4.1.1 and 4.1.2",
        "sectionTitle": "Eligibility Criteria",
        "description": "Reference for patient inclusion and exclusion criteria."
      },
      {
        "id": "ref_18",
        "name": "China Extension Analysis Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "6.11",
        "sectionTitle": "China Subpopulation Analyses",
        "description": "Reference for details on China extension data exclusion from primary analyses."
      }
    ],
    "commentAnnotations": [
      {
        "id": "annot_1",
        "text": "Substantive new information appears in italics.",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Protocol Amendment Rationale",
        "pageNumber": 4
      },
      {
        "id": "annot_2",
        "text": "This amendment represents cumulative changes to the original protocol.",
        "annotationType": "Clarification",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Protocol Amendment Rationale",
        "pageNumber": 4
      },
      {
        "id": "annot_3",
        "text": "The diagnosis of macular edema due to RVO must be confirmed by the CRC.",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Screening",
        "pageNumber": 36
      },
      {
        "id": "annot_4",
        "text": "Study treatment visits cannot occur earlier than 21 days after the previous study treatment visit.",
        "annotationType": "Clarification",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Compliance with Study Visits",
        "pageNumber": 38
      },
      {
        "id": "annot_5",
        "text": "Missed study treatments will not be made up.",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Compliance with Study Visits",
        "pageNumber": 38
      }
    ],
    "studyDefinitionDocumentVersions": [
      {
        "id": "ver_1",
        "versionNumber": "1",
        "status": "Final",
        "instanceType": "StudyDefinitionDocumentVersion",
        "versionDate": "2020-04-03",
        "description": "Original Protocol",
        "amendmentNumber": "Original"
      },
      {
        "id": "ver_2",
        "versionNumber": "2",
        "status": "Final",
        "instanceType": "StudyDefinitionDocumentVersion",
        "versionDate": "2020-11-17",
        "description": "Protocol Amendment 2: Rationale includes increasing patient sample size and adding exploratory substudies.",
        "amendmentNumber": "Amendment 1"
      }
    ],
    "summary": {
      "referenceCount": 18,
      "annotationCount": 5,
      "versionCount": 2
    }
  }
}